Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Danaher ( (DHR) ) has issued an announcement.
On February 5, 2026, Danaher Corporation announced that board member Jessica L. Mega retired from its Board of Directors, effective the same day, citing increased commitments related to her other professional obligations. The company emphasized that Dr. Mega’s departure did not stem from any disagreement over Danaher’s operations, policies, or practices, suggesting continuity in governance and strategic direction despite the change in board composition.
The most recent analyst rating on (DHR) stock is a Buy with a $270.00 price target. To see the full list of analyst forecasts on Danaher stock, see the DHR Stock Forecast page.
Spark’s Take on DHR Stock
According to Spark, TipRanks’ AI Analyst, DHR is a Neutral.
The score is driven primarily by resilient financial quality (strong margins/cash flow and improving leverage) and a generally constructive but cautious FY2026 outlook. Offsetting these positives are weak near-term technicals and a stretched valuation that raises execution sensitivity if growth/margins disappoint.
To see Spark’s full report on DHR stock, click here.
More about Danaher
Danaher Corporation is a diversified global science and technology company that operates across life sciences, diagnostics, and environmental and applied solutions. The company develops and manufactures specialized instruments, consumables, and software used by laboratories, healthcare providers, and industrial customers to support research, testing, and production workflows.
Average Trading Volume: 3,716,421
Technical Sentiment Signal: Sell
Current Market Cap: $153B
Learn more about DHR stock on TipRanks’ Stock Analysis page.